ATF4 and acute myeloid leukemia: Since up-regulation of ATF4 was reported to promote hematopoietic stem cells (HSCs) survival, we thus identified the transcription factor ATF4 to be an important biomarker guiding the different strategies for AML therapy in elderly patients.